Health Care [ 6/12 ] | Biotechnology [ 45/74 ]
NASDAQ | Common Stock
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally.
It operates through two segments, Prescription Medications and Medical Devices.
The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED).
It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease.
The company offers men's health products, including vacuum erection devices, penile injections, PreBoost, VenoSeal, and urinary tract infection tests for the treatment of erectile dysfunction.
Petros Pharmaceuticals, Inc. is based in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 15, 23 | -2.31 Decreased by -244.24% | - |
| Jun 30, 23 | -1.20 Decreased by -1.24 K% | - |
| Mar 31, 23 | -0.66 Decreased by -6.53 K% | - |
| Mar 31, 23 | -2.03 Decreased by -144.58% | - |
| Nov 14, 22 | -0.67 Decreased by -294.12% | - |
| Aug 12, 22 | -0.09 Increased by +59.09% | - |
| May 16, 22 | -0.01 Decreased by -103.23% | - |
| Mar 31, 22 | -0.83 Increased by +60.85% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 1.67 M Increased by +214.88% | -4.55 M Increased by +67.10% | Decreased by -271.67% Decreased by -128.63% |
| Jun 30, 23 | 1.99 M Decreased by -52.37% | -2.55 M Decreased by -29.79% | Decreased by -127.72% Decreased by -172.50% |
| Mar 31, 23 | 2.52 M Increased by +2.14% | -219.40 M Decreased by -6.33 K% | Decreased by -8.71 K% Decreased by -6.20 K% |
| Dec 31, 22 | 798.10 K Increased by +192.04% | -4.22 M Increased by +48.43% | Decreased by -528.93% Decreased by -156.03% |
| Sep 30, 22 | -1.46 M Decreased by -167.95% | -13.83 M Decreased by -715.03% | Increased by +948.75% Increased by +1.30 K% |
| Jun 30, 22 | 4.19 M Increased by +70.35% | -1.96 M Increased by +7.13% | Decreased by -46.87% Increased by +45.48% |
| Mar 31, 22 | 2.47 M Decreased by -39.51% | 3.52 M Increased by +17.07% | Increased by +142.90% Increased by +93.55% |
| Dec 31, 21 | -867.16 K Decreased by -129.60% | -8.19 M Decreased by -50.53% | Increased by +943.99% Increased by +608.50% |